期刊文献+

支气管哮喘患者气道炎症表型研究 被引量:54

Airway inflammatory phenotypes of asthmatic patients
原文传递
导出
摘要 目的 研究不同严重程度支气管哮喘(哮喘)患者的气道炎症表型分布,分析不同气道炎症表型的炎症标志物与肺功能特征.方法 回顾性分析中日友好医院呼吸内科2013年1月至2014年12月完成诱导痰细胞学检查的946例哮喘患者的临床资料,按照严重程度分为重症组(61例)和普通组(885例).分析重症哮喘和普通哮喘患者的气道炎症表型分布,痰细胞、呼出气一氧化氮和肺功能特征.结果 哮喘患者的气道炎症表型分布为嗜酸粒细胞型占46.6%(441/946),混合细胞型占27.5%(260/946),中性粒细胞型占21.5%(203/946),寡细胞型占4.4%(42/946),重症组与普通组的炎症表型构成比分别为44.3%、29.5%、21.3%和4.9%以及46.7%、27.4%、21.5%和4.4%,差异无统计学意义(均P>0.05).重症组患者痰嗜酸粒细胞水平为(29.1±28.5)%,高于普通组的(22.2±25.2)%,差异有统计学意义(=1.98,P<0.05);呼出气一氧化氮水平为(66.4±64.1)ppb,高于普通组的(48.0±43.7)ppb,差异有统计学意义(t=3.23,P<0.01);FEV1占预计值%为(63.7±24.1)%、FEV1/FVC为(56.4±15.1)%,均低于普通组[分别为(84.7±23.7)%和(69.1±14.5)%)],差异有统计学意义(均P<0.01).重症组气道炎症表型中,中性粒细胞型的FEV1占预计值%[(46.6±16.1)%]和FEV1/FVC比值[(45.2± 16.1)%]最低(均P<0.01).结论 哮喘患者气道炎症表型常见为嗜酸粒细胞型、混合细胞型、中性粒细胞型,中性粒细胞型重症哮喘患者肺功能损害更显著. Objective To analyze the airway inflammatory phenotypes and clinical features of severe asthma compared to mild-moderate ("common") asthma.Methods A total of 946 cases of asthma were retrospectively analyzed in our hospital from January 2013 to December 2014.Sixty-one patients were classified to the severe asthma group,and 885 patients to the common asthma group.Severe asthma was diagnosed based on the protocol from ATS/ERS guidelines.All patients received induced sputum cell counts and pulmonary function tests,and 543 of them received fractional exhaled nitric oxide (FeNO) tests.The airway inflammatory phenotypes were defined and the clinical features of patients of severe asthma were studied.Results The distribution of airway inflammatory phenotypes of asthma was as follows:eosinophilic subtype (46.6%,441/946),mixed granulocytic subtype (27.5%,260/946),neutrophilic subtype (21.5 %,203/946),and paucigranulocytic subtype (4.4%,42/946).There were no differences between the severe asthma group and the common asthma group in the distributions.Compared with common asthma patients,severe asthma patients had higher sputum eosinophil percentages (29.1% ± 28.5% vs 22.2% ± 25.2%,t =1.98,P 〈 0.05),higher FeNO values [(66.4 ± 64.1) ppb vs (48.0 ± 43.7) ppb,P 〈 0.01],lower percentages of FEV1 % pred [(63.7 ± 24.1) % vs (84.7 ± 23.7) %,P 〈 0.01],and lower ratios of FEV1/FVC [(56.4 ± 15.1) % vs (69.1 ± 14.5) % P 〈 0.01].In severe asthma patients,FeNO values were higher in the eosinophilic subtype and mixed granulocytic subtype (P 〈 0.05).Neutrophilic subtype patients had the lowest sputum eosinophil percentage [(1.8 ±0.8)%,P 〈 0.01],the lowest percentage of FEV1 % pred [(46.6 ± 16.1) %,P 〈 0.01],and the lowest ratios of FEV1/FVC [(45.2 ± 16.1) %,P 〈 0.01].Conclusions The common airway inflammatory phenotypes included eosinophilic subtype,mixed granulocytic subtype and neutrophilic subtype,in both severe and common asthma patients.Severe asthma patients had more severe eosinophilic airway inflammation and poorer lung function.Neutrophilic subtype might be the most intractable subtype with severely damaged pulmonary function in severe asthma.
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2015年第5期348-351,共4页 Chinese Journal of Tuberculosis and Respiratory Diseases
基金 卫生部行业专项课题(201002008)
关键词 哮喘 表型 炎症 一氧化氮 呼吸功能试验 Asthma Phenotype Intlammation Nitric oxide Respiratory function test
  • 相关文献

参考文献16

  • 1Gibson PG. Inflammatory phenotypes in adult asthma: clinical applications[J]. Clin Respir J,2009,3(4) :198-206.
  • 2支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗和管理方案)[J].中华结核和呼吸杂志,2008,31(3):177-185. 被引量:2517
  • 3Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma [J]. Eur Respir J, 2014,43(3) :343-373.
  • 4Bakakos P, Schleich F, Alchanatis M, et al. Induced sputum in asthma:from bench to bedside [J]. Curr Med chem, 2011,18 (10) : 1415-1422.
  • 5Simpson JL, Scott R, Boyle MJ, et al. Innammatory subtypes in asthma:Assessment and identification using induced sputum [ J ]. Respirology,2006,11 ( 1 ) :54-61.
  • 6Saraiva-Romanholo BM, Saraiva BM, Barnabe V, et al. Comparison of three methods for differential cell count in Induced sputum [ J ]. Chest,2003,124 ( 3 ) : 1060-1066.
  • 7American Thoracic Society, European Respiratory Society. ATS/ ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005 [ J ]. Am J Respir Crit Care Med, 2005,171 (8) : 912-930.
  • 8Amelink M, de Groot JC, de Nijs SB, et al. Severe adult-onset asthma: A distinct phenotype[ J]. J Allergy Clin Immunol, 2013, 132(2) :336-341.
  • 9Chung KF. New treatments for severe treatment-resistant asthma: targeting the right patient[ J]. Lancet Respir Med, 2013,1 (8) : 639-652.
  • 10Bel EH, Sousa A, Fleming L, et al. Diagnosis and definition of severe asthma: an international consensus statement from the Innovative Medicine Initiative (IMI) [ J]. Thorax, 2011, 66 (10) :910.

二级参考文献25

  • 1Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J, 2008,31:143-178.
  • 2Lex C, Fenreira F, Zacharasiewicz A, et al. Airway eosinophilia in children with severe asthma: predictive values of noninvasive tests. Am J Respir Crit Care Med, 2006, 174:1286-1291.
  • 3Lane C, Knight D, Burgess S, et al. Epithelial inducible nitric oxide synthase activity is the major deternminant of nitric oxide concentration in exhaled breath. Thorax, 2004, 59:757-760.
  • 4Zietkowski Z, Bodzenta-Lukaszyk A, Tomasiak MM, et al. Comparison of exhaled nitric oxide measurement with conventional tests in steroid-naǐve asthma patients. J Investig Allergol Clin Immunol,2006, 16:239-246.
  • 5American Thoracic Society, European Respiratory Society. ATS/ ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med,2005, 171:912-930.
  • 6Linn WS, Rappaport EB, Berhane KT, et al. Exhaled nitric oxide in a population-based study of southern California schoolchildren. Respir Res, 2009, 10:28.
  • 7Kovesi T, Kulka R, Dales R. Exhaled nitric oxide concentration is affected by age, height, and race in healthy 9 to12 year-old children. Chest, 2008, 133:169-175.
  • 8Travers J, Marsh S, Aldington S, et al. Reference ranges for exhaled nitric oxide derived from a random community survey of adults. Am J Respir Crit Care Med, 2007, 176:238-242.
  • 9Olivieri M, Talamini G, Corradi M, et al. Reference values for exhaled nitric oxide (reveno) study. Respir Res, 2006, 7:94.
  • 10Olin AC, Bake B, Toren K. Fraction of exhaled nitric oxide at 50 ml/s: reference values for adult lifelong never-smokers. Chest, 2007, 131:1852-1856.

共引文献2527

同被引文献448

引证文献54

二级引证文献409

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部